AI assistant
Evogene Ltd. — Regulatory Filings 2024
Sep 25, 2024
6785_rns_2024-09-25_94675b3f-1a13-42aa-9951-9e3a11f62b32.zip
Regulatory Filings
Open in viewerOpens in your device viewer
CORRESP 1 filename1.htm Licensed to: ZKG Document created using Broadridge PROfile 24.8.1.5246 Copyright 1995 - 2024 Broadridge
Evogene Ltd.
13 Gad Feinstein Street, Park Rehovot
Rehovot 7638517, Israel
September 25, 2024
VIA EDGAR
United States Securities and Exchange Commission Division of Corporation Finance
Office of Industrial Applications and Services 100 F Street, N.E. Washington, D.C. 20549
Attention : Conlon Danberg
| Re: |
|---|
| Registration Statement on Form F-1 |
| Filed September 19, 2024 File No. 333-282218 |
Dear Mr. Danberg:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Evogene Ltd. hereby requests that the effective date of the above-referenced Registration Statement on Form F-1 be accelerated so that it will become effective at 9:00 a.m. Eastern time on September 27, 2024, or as soon as practicable thereafter.
Please contact our outside counsel, Meitar Law Offices (Mike Rimon, Adv. at +972-3-6145822 or [email protected] , Jonathan M. Nathan, Adv. at +972-3-610-3157 or [email protected] , or Elad Ziv, Adv. at+972-3-6142613 or [email protected] ) with any questions, and please notify them when this request for acceleration has been granted.
| Sincerely, | ||
|---|---|---|
| EVOGENE LTD. | ||
| By: | /s/ Ofer Haviv | |
| Name: Ofer Haviv | ||
| Title: President and Chief Executive Officer | ||
| cc: | Meitar Law Offices Mike Rimon, Adv. | |
| Jonathan M. Nathan, Adv. Elad Ziv, Adv. |